4//SEC Filing
WALTON ALAN G 4
Accession 0001214273-09-000005
CIK 0001070494other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:22 PM ET
Size
8.3 KB
Accession
0001214273-09-000005
Insider Transaction Report
Form 4
WALTON ALAN G
Director
Transactions
- Award
Stock Option (Right to Buy)
2009-06-12+10,000→ 10,000 totalExercise: $2.16Exp: 2019-06-11→ Common Stock (10,000 underlying) - Award
Stock Option (Right to Buy)
2009-06-12+34,722→ 34,722 totalExercise: $2.16Exp: 2019-06-11→ Common Stock (34,722 underlying)
Footnotes (2)
- [F1]One-fourth of the shares subject to the Stock Option shall vest and become exercisable at the end of each three-month period following June 12, 2009.
- [F2]The Reporting Person has elected to convert an annual retainer fee of $25,000 into a Stock Option under the terms of the Issuer's Outside Director Compensation Program.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001214273
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:22 PM ET
- Size
- 8.3 KB